drugset / Trial / NCT00382291

Effectiveness of Sertraline and Cognitive Behavioral Therapy in Treating Pediatric Obsessive-Compulsive Disorder

NCT00382291 ↗

RandomizedParallel-groupQuadruple-blindDiagnostic

Summary

This study measures the occurrence of certain side effects linked to antidepressant use and evaluates the effectiveness of the medication sertraline plus cognitive behavioral therapy to treat people with obsessive-compulsive disorder.

Timeline

Start
2009-02
Primary completion
2011-02
Completion
2011-02

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Placebo vs Regular Titration vs Slow Titration; p = .2106; Kruskal-Wallis NCT00382291 ↗

registry analysis (superiority or other test); Placebo vs Regular Titration vs Slow Titration; p = .8831; ANCOVA NCT00382291 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 200 mg —